APA (7th ed.) Citation

Fu Peng, Fu Peng, Fu Peng, Liang Xiong, Xiaofang Xie, Hailin Tang, . . . Cheng Peng. (2020). Isoliquiritigenin Derivative Regulates miR-374a/BAX Axis to Suppress Triple-Negative Breast Cancer Tumorigenesis and Development. Frontiers Media S.A..

Chicago Style (17th ed.) Citation

Fu Peng, Fu Peng, Fu Peng, Liang Xiong, Xiaofang Xie, Hailin Tang, Ruizhen Huang, and Cheng Peng. Isoliquiritigenin Derivative Regulates MiR-374a/BAX Axis to Suppress Triple-Negative Breast Cancer Tumorigenesis and Development. Frontiers Media S.A., 2020.

MLA (9th ed.) Citation

Fu Peng, et al. Isoliquiritigenin Derivative Regulates MiR-374a/BAX Axis to Suppress Triple-Negative Breast Cancer Tumorigenesis and Development. Frontiers Media S.A., 2020.